Inventor · disambiguated record
Mads Daugaard
Also filed as: DAUGAARD MADS
5 granted patents·4 pending applications·1 citations·filing 2013–2023
64Inventor score
Files withVAR2 PHARMACEUTICALS APS4ZYMEWORKS INC2BACHA JEFFREY A1DEL MAR PHARMACEUTICALS BC LTD1VARCT DIAGNOSTIC APS1
Top patents by PatentIndex Score
9 records- 0169US9926350B2Targeting of chondroitin sulfate glycansVAR2 PHARMACEUTICALS APS·Filed 2016·Granted Mar 27, 2018·1 cites·10 claims
- 0255US11787844B2Targeting of chondroitin sulfate glycansVAR2 PHARMACEUTICALS APS·Filed 2013·Granted Oct 17, 2023·0 cites·13 claims
- 0352US10675355B2VAR2CSA-drug conjugatesZYMEWORKS INC·Filed 2014·Granted Jun 9, 2020·0 cites·43 claims
- 0452US9932375B2Targeting of chondroitin sulfate glycansVAR2 PHARMACEUTICALS APS·Filed 2016·Granted Apr 3, 2018·0 cites·7 claims
- 0550US2025179211A1Antibodies and antibody fragments and analogues specific for chondroitin sulfateVAR2 PHARMACEUTICALS APS·Filed 2023·Application pending·0 cites
- 0645US10517958B2Compositions and methods for the treatment of platinum-drug resistant cancerZYMEWORKS INC·Filed 2017·Granted Dec 31, 2019·0 cites·50 claims
- 0743US2020061054A1Use of dianhydrogalactitol or analogs and derivatives in combination with a p53 modulator or a parp inhibitorDEL MAR PHARMACEUTICALS BC LTD·Filed 2018·Application pending·0 cites
- 0840US2021278406A1Isolation of circulating cells of fetal origin using recombinant malaria protein var2csaVARCT DIAGNOSTIC APS·Filed 2019·Application pending·0 cites
- 0936US2019091195A1Use of dianhydrogalactitol and derivatives thereof in the treatment of glioblastoma, lung cancer, and ovarian cancerBACHA JEFFREY A·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mads Daugaard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →